Coronavirus: Taiwan expects to roll out locally made vaccines by end of July
- President Tsai Ing-wen makes announcement as the island faces an outbreak of cases
- She says phase 2 trials have nearly been completed and calls for calm over community transmission
“The first wave of locally developed vaccines is expected to be ready for supply at the end of July,” she said, without giving details on how many vaccines would be available or which ones.
Two experimental vaccines developed by Taiwanese companies – Medigen Vaccine Biologics Corporation and United Biomedical – are in phase 2 trials, both involving more than 4,000 volunteers.
Both companies are expected to apply for “emergency use authorisation” in June, according to local media reports.
A Medigen Vaccine Biologics spokesman said last month that antibody tests had indicated their candidate appeared to be effective in protecting against the UK variant while it was slightly less effective against the South African variant, according to a Taiwan News report.
Meanwhile, Hwang Kao-pin of the China Medical University Hospital in Taipei, who heads the United Biomedical vaccine project, said their experimental shot had also delivered satisfactory results against both the UK and South African variants, according to the report.
Taiwan to boost spending by US$7.5 billion as Covid-19 cases rise
Tsai said shipments of vaccines from overseas were expected to arrive next month.
“Relevant authorities should get ready for the arrival of these vaccines and prepare to administer them,” she said.
More than 120,000 people had been inoculated as of Thursday – a big jump from the 70,000 who had received the jab a week ago, according to the Central Epidemic Command Centre.
The centre reported 13 new locally transmitted cases on Thursday, taking the number of local infections in the outbreak to 71 – after recording no such cases over the past few months. Taiwan has reported a total of 1,256 infections and 12 deaths during the pandemic.